Jörg Neermann

Provides investment and corporate banking & asset management services

Develops drugs for cancer treatment

Provides biomarker services for pharmaceutical and biotech companies globally

Discovers and develops antibody-based therapeutic drugs

EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million.

Develops and markets pharmaceuticals

DVC is a venture capital investment manager focused on European high-growth, early-stage companies with global expansion potential. The firm invests in sectors including life sciences, information technology, telecommunication, semiconductor and industrial technologies. In the field of life sciences, DVC invests specifically in the development of therapeutic products, diagnostics, medical devices and biotechnology platforms. Their technology investments target businesses whose activity pertains to 1) the management of information, applications and infrastructure, 2) communication applications and platforms as well as network infrastructure, and 3) technologies related to optics, automation, sensors, electronics, semiconductors and materials. DVC aims to leverage their access to Deutsche Bank's international network and lead their portfolio companies from technological leadership to international market success. Investment criteria include distinctive technology with adequate IP protection and addressing a clearly identified market, an experienced management team and leadership potential in high-growth markets internationally. The firm is generally the lead investor in German-speaking countries, and co-leads in other European countries and the US. They aim to keep their portfolio balanced across their target sectors and across development stages, with a majority of early-stage investments complemented with expansion-phase investments with short-term exit potential. DVC actively assists their portfolio companies with financial issues, key hires and marketing strategy without interfering in operational management.

Discovers and develops drugs for biosurgery, tissue repair and regeneration

Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements.